Delivery Order SPE2DR25D1052-SPE2DR26F6CV4
- Not listed
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $1,891.40 delivery order to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials under a firm fixed price contract. This non-set-aside award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atropine is a critical medication used in military and federal healthcare settings for emergency medical treatment,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,213.36 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/ml vial supplies, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $1,312.85 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL). The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was competitively awarded with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a $12,393.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL in quantities of 10 units, with an ultimate completion date of December 29, 2025. This non-set-aside contract was competitively awarded on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,074.04 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atropine 1 mg/mL in vial form, with an ultimate completion date of September 18, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.07 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This firm fixed price contract, with an ultimate completion date of November 28, 2025, represents a non-competitive, non-set-aside procurement executed on November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6CV4Delivery Order
The Defense Logistics Agency awarded a $1,127.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract reflects standard pharmaceutical procurement practices for federal medical supply chain operations. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., operates this comprehensive pharmaceutical supply vehicle that enables the delivery of a broad range of medications, vaccines, syringes, vials, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. Atropine is a critical pharmaceutical for emergency medical applications, and this order supports the broader mission of maintaining adequate pharmaceutical inventories for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/15/26 |